Systemic lupus erythematosus: one year in review 2026

Area of Science:

• Rheumatology and Immunology
• Autoimmune Diseases
• Systemic Lupus Erythematosus (SLE) Research

Background:

• Systemic Lupus Erythematosus (SLE) is a chronic autoimmune condition with complex causes, varied symptoms, and unpredictable progression.
• Understanding SLE's multifaceted nature is crucial for effective patient management and therapeutic development.

Purpose of the Study:

• To provide a comprehensive overview of significant research published in 2025 concerning Systemic Lupus Erythematosus (SLE).
• To synthesize key findings on SLE pathogenesis, biomarkers, clinical features, comorbidities, and treatment efficacy from recent clinical trials and real-world data.

Main Methods:

• Systematic review of scientific literature published in 2025 related to Systemic Lupus Erythematosus (SLE).
• Focus on emerging pathogenetic insights, novel biomarkers, clinical manifestations, outcomes, comorbidities, and evidence from clinical trials and real-world studies.

Main Results:

• Identification of emerging pathogenetic pathways contributing to SLE.
• Evaluation of novel and refined biomarkers for SLE diagnosis and monitoring.
• Analysis of clinical manifestations, patient outcomes, and the impact of comorbidities in SLE.
• Assessment of recent clinical trial data and real-world evidence for SLE management.

Conclusions:

• Significant progress has been made in understanding SLE pathogenesis and identifying potential therapeutic targets.
• Refined biomarkers and new clinical insights offer improved diagnostic and prognostic capabilities for SLE.
• Despite advancements, persistent unmet needs remain in the comprehensive management and treatment of Systemic Lupus Erythematosus (SLE).